Mutations of components of SWI/SNF complex are frequently observed in numerous human cancers; however, the underlying mechanisms by which SWI/SNF components contribute to tumorigenesis or drug sensitivity warrant further investigation. This evidence concerns the gene SMARCA1 and cancer.